To apply, please email your non-confidential company presentation to GoldenTicket@abbvie.com by October 19th, 2021.
In the application, please address:
What is the scientific insight and approach driving your company?
If successful, how would your therapeutic approach provide significant patient benefit beyond currently available treatment or other R&D stage programs?
Selected applicants will be invited to present their company to an expert AbbVie leadership panel at an event to be held virtually on December 2nd, 2021.
We look forward to receiving your application. Contact us with any questions at GoldenTicket@abbvie.com or Flavia.Nachbar@mbcbiolabs.com